Rise and shine, everyone, another busy day is on the way. A bright sun is warming the Pharmalot corporate campus this morning as we scramble to play catch up after being at a conference yesterday. So much to do, so little time, as they say. To cope, we are brewing a cup of stimulation in hopes of regaining some equilibrium and, of course, invite you to join us. Nothing like feeling well balanced, yes? Meanwhile, here are some tidbits to help you along. Have a great day and drop us a line if you hear something interesting...
EU Court Upholds AstraZeneca Fine Over Ulcer Drug (Reuters)
UK NICE OKs Bristol Arthritis Drug After Price Cut (Reuters)
Drugmakers Offer UK Big Discounts: NICE Chairman (Bloomberg News)
Another Pharma Free Speech Will Be Reviewed By A Court (Wall Street Journal)
Pharma Criticizes Indian Foreign Investment Decision (Economic Times)
Windsor Pharmaceutical To Close Nova Scotia Facility (Nova News)
Drugmakers And Universities Form Stem Cell Bank (Bloomberg News)
Teva CEO Readies For Big Investor Meeting (Reuters)
Tamoxifen Should Be Taken Twice As Long: Study (New York Times)
Pipeline Failures Prompt Two Biotechs To Cut Jobs (Pharma Times)
FDA Staff Says Zogenix Drug Has Abuse Risks (Bloomberg News)
Lilly Tests Med To Rid Brain Plaques In Mice With Alzheimer's (Reuters)
Pfizer Experimental Drug Slows Late-Stage Breast Cancer (Bloomberg News)
EDITOR'S NOTE: Please check this post for updates